Request Trial
blankrome-sign
26 January 2023Muireann Bolger

Blank Rome hires new patent agent for Texas office

Blank Rome has brought in patent agent  Joseph Jackson to the firm’s IP and Technology practice group in Houston.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
Scientist and Chinese biotech targeted by Beam in secrets suit
29 September 2026   The gene-editing company has accused a former employee of secretly co-founding a Chinese biotech while still at the company, in a trade secrets lawsuit involving rival base-editing therapies and disputed patent filings.
Careers
Clifford Chance recruits new head of Asia-Pac
29 September 2026   As partner and head of IP for the region, the Hong Kong-based hire brings extensive experience advising on the IP aspects of complex corporate transactions and investments.
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026   Can a drug’s ‘inactive’ precursor qualify for a multi-million pound patent extension? The UK High Court has just delivered a ruling on Takeda's ADHD drug Elvanse, weighing regulatory precedent against a conflicting German decision.


Editor's picks

Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

Editor's picks

Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026
Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

More features

Scientist and Chinese biotech targeted by Beam in secrets suit
Clifford Chance recruits new head of Asia-Pac
Takeda sees off UK challenge to Elvanse SPC
Conley Rose welcomes back former employee with legal and business nous
Mylan throws down new gauntlet in Novo Wegovy patent fight
Novartis defeats Orange Book challenge but suffers EU setback
New UK High Court judge named as replacement for Justice Meade
US firm hires litigation pro whose clients include Pfizer, Medtronic